Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' first generation continuous glucose monitoring (CGM) system, Eversense®, includes a small sensor, smart transmitter and mobile application. Based on fluorescence sensing technology, the sensor is designed to be inserted subcutaneously and communicate with the smart transmitter to wirelessly transmit glucose levels to a mobile device. After insertion, the sensor is designed to continually and accurately measure glucose levels. For more information on Senseonics, please visit www.senseonics.com.
Introducing the latest advance in glucose monitoring. The Eversense CGM System includes an implantable sensor that lasts up to 90 days, a removable smart transmitter, and an easy-to-use mobile app. All wirelessly connected and designed to provide a new level of confidence and peace of mind in glucose monitoring.